Records containing: Secondary Myelodysplastic Syndromes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-04-17A Phase II Study of and Oral Histone Deacytylase Inhibitor, MS-275 (NSC 706995), in Combination With Sargramostim (GM-CSF, Berlex, Inc.) Treating Relapsed and Refractory Myeloid Malignancies
-
CLINICAL_TRIALS study record update · 2017-03-31A Pilot Study of Combined Plerixafor + Filgrastim for Mobilization of Peripheral Blood Stem Cells From Normal Donors
-
CLINICAL_TRIALS study record update · 2017-02-15A Phase II Study of Tosedostat in Combination With Either Cytarabine or Decitabine in Newly Diagnosed AML or High-Risk MDS
-
CLINICAL_TRIALS study record update · 2017-01-20A Pilot Study to Evaluate the Potential Efficacy of Lithium Carbonate for Stimulation of Intestinal Recovery In Patients With Acute Graft-versus-host Disease (GVHD)
-
CLINICAL_TRIALS study record update · 2016-07-14Hematopoietic Stem Cell Transplantation Using Alternate Donor Umbilical Cord Blood Options
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-06-13A Pilot Trial Of Reduced Intensity Allogeneic Stem Cell Transplantation With Fludarabine, Melphalan, And Low Dose Total Body Irradiation
-
CLINICAL_TRIALS study record update · 2016-05-17Identification of de Novo Fanconi Anemia Patients Using FANCD2 Western Blots
-
CLINICAL_TRIALS study record update · 2015-12-04Phase I and Pharmacodynamic Study of GTI-2040 (NSC 722929, IND 67368) in Acute Leukemias
-
CLINICAL_TRIALS study record update · 2015-06-08A Phase I Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) in Myeloid Leukemia and MDS
-
CLINICAL_TRIALS study record update · 2015-02-11A Pilot Study to Evaluate the Co-infusion of Ex Vivo Expanded Umbilical Cord Blood Progenitors With an Unmanipulated Cord Blood Graft in Patients Undergoing Umbilical Cord Blood Transplantation for Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2015-01-13The Treatment of Down Syndrome Children With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Under the Age of 4 Years
-
CLINICAL_TRIALS study record update · 2015-01-08A Phase II Study of VEGF Trap (NSC 724770) in Patients With MDS
-
CLINICAL_TRIALS study record update · 2014-09-01A Phase II Study of Sunitinib Malate (Sutent®; SU11248) in Patients With Intermediate-2 or High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
-
CLINICAL_TRIALS study record update · 2014-06-11Phase I Study of CC-5013 (Lenalidomide NSC# 703813) in Pediatric Patients With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2014-04-02A Preliminary Study to Evaluate the Effects of Palifermin in Patients at Risk of Chronic Graft-versus-host Disease
-
CLINICAL_TRIALS study record update · 2014-02-14Soluble Tumor Necrosis Factor Receptor: Enbrel® (Etanercept) for the Treatment of Acute Non-Infectious Pulmonary Dysfunction (Idiopathic Pneumonia Syndrome) Following Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2013-10-28A Multi-center Phase III Study Comparing Myeloablative to Nonmyeloablative Transplant Conditioning in Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
-
CLINICAL_TRIALS study record update · 2013-09-30A Phase 1 Study of Suberoylanilide Hydroxamic Acid (Vorinostat, SAHA) in Combination With Idarubicin in Relapsed or Refractory Leukemia
-
CLINICAL_TRIALS study record update · 2013-09-30Phase I Study of 5-Aza-2'-Deoxycytidine (Decitabine) as a Biologic Modifier of Retinoid Responsive Genes in Patients With High-Risk Myelodysplastic Syndromes and Acute Myelogenous Leukemia (De-novo, Relapsed or Secondary)
-
CLINICAL_TRIALS study record update · 2013-09-30A Phase I Study of SJG-136 in Patients With Advanced Leukemia
-
CLINICAL_TRIALS study record update · 2013-09-30A Phase I And Pharmacological Trial Of 17-Allylamino -17-demethoxygeldanamycin (17-AAG) And Cytarabine In Refractory Leukemia And Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2013-07-10A Phase II Study of AZD2171 in the Treatment of Patients With Acute Leukemia and Myelodysplastic Syndrome.
-
CLINICAL_TRIALS study record update · 2013-05-03Phase I Study of Vorinostat (Suberoylanilide Hydroxamic Acid, or SAHA) in Combination With Cytosine Arabinoside (Ara-C) and Etoposide for Patients With Relapsed and/or Refractory Acute Leukemias, Myelodysplasias and Myeloproliferative Disorders
-
CLINICAL_TRIALS study record update · 2013-03-20Phase II Study of the Histone Deacetylase Inhibitor PXD101 for the Treatment of Myelodysplastic Syndrome
-
CLINICAL_TRIALS study record update · 2013-02-08A Phase I Study of XK469R (NSC 698215) in Patients With Refractory Hematologic Malignancies